How is the INmune Bio Inc today?

The INmune Bio Inc today is trading in the green, up by 0.54% at 7.50.

What is INmune Bio Inc Annual Revenue?

INmune Bio Inc Annual Revenue fell 90.97%, in the last year to $0.01 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is INmune Bio Inc Annual Net Profit?

INmune Bio Inc Annual Net Profit fell 40.24% in the last year to $42.08 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is INmune Bio Inc Price to Earning Ratio?

INmune Bio Inc Price to Earning Ratio is -4.27, which is negative.

What is INmune Bio Inc Stock Price?

INmune Bio Inc Stock Price fell 28.98% and underperformed its sector by 40.52% in the past year.

What is INmune Bio Inc Quarterly Revenue?

INmune Bio Inc Quarterly Revenue rose 257.14% YoY to $0.05 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is INmune Bio Inc Quarterly Net profit?

INmune Bio Inc Quarterly Net profit rose 11.66% YoY to $9.74 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is INmune Bio Inc Debt to Equity Ratio?

INmune Bio Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is INmune Bio Inc Return on Equity(ROE)?

INmune Bio Inc Return on Equity(ROE) for the last financial year was -119.83%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is INmune Bio Inc Mutual Fund Holding?

INmune Bio Inc Mutual Fund Holding decreased by 0.11% in the last quarter to 14.23.

What is INmune Bio Inc Promoter Share Holding?

INmune Bio Inc Promoter Share Holding stayed the same in the most recent quarter at 43.22%.

What is INmune Bio Inc Institutional Holding?

INmune Bio Inc Institutional Holding decreased by 1.34% in the last quarter to 27.8.

INmune Bio Inc XNAS: INMB

INmune Bio Inc Live Share Price Today, Share Analysis and Chart

Name: INmune Bio Inc: Is Infosys Ltd. worth buying?
Item: INmune Bio Inc
Rating: 1.55816675
Author: Trendlyne DVM scores

about

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune,...

7.50 0.04 (0.54%)

32.00% Fall from 52W High

341.0K XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

3.7 / 100

Technically Neutral

58.7 / 100

23

1Yr Price target upside is 212%

5 analysts

INmune Bio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

INmune Bio Inc FAQ

How is INmune Bio Inc today?

INmune Bio Inc today is trading in the green, and is up by 0.54% at 7.50.

How has INmune Bio Inc performed historically?

INmune Bio Inc is currently trading up 0.54% on an intraday basis. In the past week the stock rose 0.94%. stock has been down -12.69% in the past quarter and fell -28.98% in the past year. You can view this in the overview section.